Evidence map›Paper›PMID 30973074›Full record

ArticleTissue engineering. Part A2019

Effects of Bone Morphogenetic Protein-2 on Neovascularization During Large Bone Defect Regeneration.

Hope B Pearson, Devon E Mason, Christopher D Kegelman, Liming Zhao, James H Dawahare, Melissa A Kacena, Joel D Boerckel

Open access · greenAbstract read
In one paragraph

Article in Tissue engineering. Part A, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Thrombopoietic agents enhance bone healing in mice, rats, and pigs.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Strategies forBiomedical reports · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Hope B PearsonDepartment of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, Indiana.
Devon E MasonDepartment of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, Indiana.
Christopher D KegelmanDepartment of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, Pennsylvania.
Liming ZhaoDepartment of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
James H DawahareDepartment of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, Indiana.
Melissa A KacenaDepartment of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, Indiana.
Joel D BoerckelDepartment of Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, Indiana.
University of Pennsylvania · USUniversity of Notre Dame · USIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Mechanical regulation of endochondral bone regenerationR01AR074948 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI BOERCKEL, JOEL D · 2019 to 2023
$1.7M
Impact of TPO Treatment on Bone Healing and Angiogenesis in Type 2 DiabetesI01BX003751 · VA · RLR VA MEDICAL CENTER · PI KACENA, MELISSA A · 2017 to 2021
–
BLRD VA I01 BX003751NCATS NIH HHS UL1 TR001108NIAMS NIH HHS R01 AR074948
6 · The paper itself

Abstract

Insufficient blood vessel supply is a primary limiting factor for regenerative approaches to large bone defect repair. Recombinant bone morphogenetic protein-2 (BMP-2) delivery induces robust bone formation and has been observed to enhance neovascularization, but whether the angiogenic effects of BMP-2 are due to direct endothelial cell stimulation or due to indirect paracrine signaling remain unclear. In this study, we evaluated the effects of BMP-2 delivery on vascularized bone regeneration and tested whether BMP-2 induces neovascularization directly or indirectly. We found that delivery of BMP-2 (5 μg) enhanced both bone formation and neovascularization in critically sized (8 mm) rat femoral bone defects; however, BMP-2 did not directly stimulate angiogenesis

Indexed as

AnimalsBone Morphogenetic Protein 2Bone RegenerationCell MovementChoristomaColony-Forming Units AssayCulture Media, ConditionedEndothelial CellsFemaleFemurHumansMesenchymal Stem CellsMiceNeovascularization, PhysiologicOsteoblastsOsteogenesisBone Morphogenetic Protein 2Culture Media, ConditionedangiogenesisBMP-2bone defectbone regeneration

Identifiers

PMID30973074
PMCPMC6919258
OpenAlexW2900408879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.